GMF(SZ:002551)2026-01-23 08:45Financial Performance Expectations - The company expects a net profit in the range of -¥17,000,000 to -¥12,000,000 for the fiscal year 2025, compared to a profit of ¥2,228,200 in the same period last year[4] - The net profit after deducting non-recurring gains and losses is projected to be between -¥18,619,260 and -¥13,619,260, down from ¥1,165,810 in the previous year[4] - Basic earnings per share are expected to be between -¥0.2011 and -¥0.1420, compared to ¥0.0264 in the same period last year[4] Revenue and Project Performance - The decrease in performance is primarily due to a reduction in hospital engineering projects, leading to decreased revenue from medical engineering services[6] - Revenue from medical consumables exports has decreased due to international market conditions, resulting in lower gross margins[6] Financial Provisions and Losses - The company has increased its provision for bad debts due to lower-than-expected collections from hospital engineering projects[6] - The company has increased its asset impairment provisions during the reporting period[7] - Exchange rate fluctuations have led to increased foreign exchange losses for the company[7] Reporting and Investor Guidance - The financial data presented is preliminary and has not been audited, with final figures to be confirmed in the 2025 annual report[8] - Investors are advised to refer to designated media for official disclosures and to be aware of investment risks[9]